Physician-guided supplementation may be considered to support the bodys antioxidant defenses but dosages and administration should be tailored to an individuals health history and goals, says Dr
Who Is B12 Injection For
Sc., Ph.D., FIDSA.,, DAYLAN PEREIRA, Pooja Bhartur, ACS Publications Society of Cosmetic Chemists HQ IFSCC Congress Cosmetic Ingredient Review CIRS Group American Academy of Dermatology British Association of Dermatologists PCPC, IADVL National Resident Commitee, Journal of Investigative Dermatology, Dermatology Times, European Academy of Dermatology and Venereology, Skin Health Alliance, The National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) #Dermatology #SkinResearch #BlueLight #Photoprotection #CosmeticScience To view or add a comment, sign in 8,061 followers
The expected timeline: Phase 3 trials completing: Results rolling out throughout the rest of this year FDA submission: Expected sometime after full Phase 3 data is available Potential FDA approval: Estimated for late 2027 at the earliest Commercial availability: If approved, launch would follow in 2027-2028 For those tracking retatrutide availability updates , the situation is evolving
